Platelet-rich plasma for the treatment of androgenetic alopecia - A randomized placebo-controlled pilot study

Platelet-rich plasma for the treatment of androgenetic alopecia - A randomized placebo-controlled pilot study - PRP for the Treatment of AGA

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00019891

Enrollment

Registered

2019-12-09

Start date

2017-08-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

L64 L65

Interventions

Group 1: Platelet rich plasma injections Group 2: Placebo injections (Saline)

Eligibility

Sex/Gender

Male

Age

18 Years to 55 Years

Inclusion criteria

Inclusion criteria: - Male patients with AGA Norwood-Hamilton = 3 - Age 18 – 55 years - Untreated androgenetic alopecia - signed informed consent

Exclusion criteria

Exclusion criteria: - Patients with previously or ongoing treatment for AGA (Finasteride, Minoxidil) - Condition after hair transplantation - Malignancy, haematological disorders, thyroid dysfunction, malnutrition and other dermatological disorders contributing to hair loss

Design outcomes

Primary

Measure	Time frame
Increase in hair density and hair thickness measured with the trichoscan	—

Secondary

Measure	Time frame
Improved clinical appearance measured on the Norwood-Hamilton scale	—

Countries

Austria

Contacts

Public ContactPaul Gressenberger

Medizinische Universität Graz

paul.gressenberger@medunigraz.at+43316-385-80786

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026